A Multicenter Randomized Open-label Study of Diammonium Glycyrrhizinate Enteric-coated Capsule Plus DXM Versus DXM in Treatment of ITP

Summary

The project was undertaking by Qilu Hospital of Shandong University in China. In order to report the efficacy and safety of diammonium glycyrrhizinate enteric-coated capsule plus high-dose dexamethasone for the treatment of adults with newly-diagnosed primary immune thrombocytopenia (ITP).

Timeline

Start

2021-08-21

Primary completion

2021-08-21

Completion

2026-01-31

Publications

• Wang H, Wang R, Yuan C, Bi K, Xiao T, Teng Q, Wang H, Yu J, Hou M, Hou Y. A multicentre randomized open-label phase 2 trial of dexamethasone plus glycyrrhizinate versus dexamethasone in newly diagnosed immune thrombocytopenia. Br J Haematol. 2026 May 24. doi: 10.1111/bjh.70574. Online ahead of print.

Drugs

Indications